Search research articles
Contact Us
Filters
Showing results (601-610 of 738) with videos related to
Page
of 74
Sort By:
Circulation. Heart Failure
|
January 28, 2010
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies
C Barrett Bowling, Bertram Pitt, Mustafa I Ahmed, et al.
Circulation
|
June 27, 2018
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
European Heart Journal
|
November 13, 2012
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis
Dharam J Kumbhani, P Gabriel Steg, Christopher P Cannon, et al.
Annals of Internal Medicine
|
December 4, 2023
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis
Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, et al.
JAMA Cardiology
|
June 14, 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
Rajiv Agarwal, Bertram Pitt, Peter Rossing, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 25, 2007
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI
V Fonseca, G L Bakris, D S H Bell, et al.
Circulation
|
March 26, 2008
N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK)
B C Astor, S Yi, L Hiremath, et al.
International Journal of Cardiology
|
November 6, 2012
The past, present and future of renin-angiotensin aldosterone system inhibition
Robert J Mentz, George L Bakris, Bernard Waeber, et al.
Diabetes, Obesity & Metabolism
|
August 14, 2023
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials
Hiddo J L Heerspink, Priya Vart, Niels Jongs, et al.
Diabetes Care
|
July 29, 2025
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Peter Rossing, George Bakris, Vlado Perkovic, et al.
Page
of 74
Search research articles
Search
Showing results (601-610 of 738) with videos related to
Sort By:
Page
of 74
Circulation. Heart Failure
|
January 28, 2010
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies
C Barrett Bowling, Bertram Pitt, Mustafa I Ahmed, et al.
Circulation
|
June 27, 2018
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
European Heart Journal
|
November 13, 2012
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis
Dharam J Kumbhani, P Gabriel Steg, Christopher P Cannon, et al.
Annals of Internal Medicine
|
December 4, 2023
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis
Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, et al.
JAMA Cardiology
|
June 14, 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
Rajiv Agarwal, Bertram Pitt, Peter Rossing, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 25, 2007
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI
V Fonseca, G L Bakris, D S H Bell, et al.
Circulation
|
March 26, 2008
N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK)
B C Astor, S Yi, L Hiremath, et al.
International Journal of Cardiology
|
November 6, 2012
The past, present and future of renin-angiotensin aldosterone system inhibition
Robert J Mentz, George L Bakris, Bernard Waeber, et al.
Diabetes, Obesity & Metabolism
|
August 14, 2023
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials
Hiddo J L Heerspink, Priya Vart, Niels Jongs, et al.
Diabetes Care
|
July 29, 2025
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Peter Rossing, George Bakris, Vlado Perkovic, et al.
Page
of 74